Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2016 Jul-Aug;48(4):453-454.
doi: 10.4103/0253-7613.186203.

Melasma: A rare adverse effect of clomipramine

Sujita Kumar Kar  1
Affiliations
Case Reports

Melasma: A rare adverse effect of clomipramine

Sujita Kumar Kar. Indian J Pharmacol. 2016 Jul-Aug.

Abstract

Melasma is a hyperpigmented dermatological condition common in females. Drugs such as steroids, cosmetics, and photosensitizing agents are known to cause melasma. We report here a case of an adult male with obsessive-compulsive disorder, receiving clomipramine, who developed melasma.

Keywords: Clomipramine; melasma; obsessive-compulsive disorder.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

  • Update on Melasma-Part II: Treatment.
    Cassiano DP, Espósito ACC, da Silva CN, Lima PB, Dias JAF, Hassun K, Miot LDB, Miot HA, Bagatin E. Cassiano DP, et al. Dermatol Ther (Heidelb). 2022 Sep;12(9):1989-2012. doi: 10.1007/s13555-022-00780-4. Epub 2022 Jul 29. Dermatol Ther (Heidelb). 2022. PMID: 35906506 Free PMC article. Review.
  • Melasma: A Condition of Asian Skin.
    Wu MX, Antony R, Mayrovitz HN. Wu MX, et al. Cureus. 2021 Apr 10;13(4):e14398. doi: 10.7759/cureus.14398. Cureus. 2021. PMID: 33987053 Free PMC article. Review.

References

    1. Handel AC, Miot LD, Miot HA. Melasma: A clinical and epidemiological review. An Bras Dermatol. 2014;89:771–82. - PMC - PubMed
    1. Dereure O. Drug-induced skin pigmentation. Epidemiology, diagnosis and treatment. Am J Clin Dermatol. 2001;2:253–62. - PubMed
    1. Mårs U, Larsson BS. Pheomelanin as a binding site for drugs and chemicals. Pigment Cell Res. 1999;12:266–74. - PubMed
    1. Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, et al. Amethod for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981;30:239–45. - PubMed
    1. Uppsala: The Uppsala Monitoring Centre; 2005. World Health Organization. The use of the WHO-UMC system for standardized case causality assessment.

Publication types

MeSH terms

Substances

LinkOut - more resources